Research Overview of Ultima-Hexarelin
Hexarelin is a synthetic growth hormone releasing peptide (GHRP) belonging to the hexapeptide class of compounds. This peptide functions as a potent growth hormone secretagogue, activating specific receptor pathways in cellular research models. Ultima Peptides formulates this compound at 2mg concentration for precise laboratory investigations.
Research teams across the UK utilise Stroid UK Shop for accessing high-grade research peptides. The hexapeptide structure of hexarelin demonstrates notable stability in laboratory conditions, making it suitable for extended research protocols examining growth hormone axis modulation.
Laboratory Research Applications
Hexarelin demonstrates significant activity in preclinical models investigating growth hormone release pathways. Research studies have examined its interaction with growth hormone secretagogue receptors (GHS-R) in various tissue types. The compound shows efficacy in stimulating growth hormone secretion through both hypothalamic and direct pituitary mechanisms in animal models.
Academic institutions frequently examine hexarelin alongside other peptides for comparative studies in growth hormone biology. The compound’s potency relative to other growth hormone releasing peptides makes it valuable for dose-response relationship investigations. Researchers have documented its effects on insulin-like growth factor-1 (IGF-1) elevation in cell culture systems.
Studies exploring hexarelin’s cardiovascular applications demonstrate its interaction with cardiac tissue receptors. The peptide’s influence on cardiac protection mechanisms provides insights for cardiovascular research applications. Additionally, investigations into hexarelin peptid formulations examine potential neuroprotective properties through growth hormone-mediated pathways.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Hexarelin |
| Manufacturer | Ultima Peptides |
| Quantity | 2mg |
| Molecular Formula | Verify with supplier |
| CAS Number | Verify with supplier |
| Storage Conditions | -20°C (lyophilised powder) |
Comparative research with SARMs provides insights into different growth-promoting mechanisms. While SARMs target androgen receptors, hexarelin specifically activates growth hormone pathways, offering researchers distinct experimental approaches for studying anabolic processes in laboratory settings.
Research Compliance Statement
Ultima-Hexarelin 2mg is manufactured exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain proper laboratory protocols and safety measures when handling this research peptide. All studies should comply with institutional research guidelines and applicable regulations governing peptide research compounds.
